文献速递中毒与环境急症重症综合管理与镇静镇痛

瑞典新型精神活性物质苯二氮䓬类中毒的发生与时间进程:STRIDA项目结果

Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project.
PubMed 文献 · Clin Toxicol (Phila) · 2018-10-22
一句话结论瑞典STRIDA项目2012-2016年急性中毒病例中,11%检出NPS苯二氮䓬类,检出率从2012年4%升至2015年19%,少数需ICU监护并对氟马西尼治疗有阳性反应。

该研究为STRIDA项目连续病例系列,纳入2012-2016年瑞典全国医院急诊收治的疑似或承认摄入NPS的患者,尿液用免疫分析和液相色谱-高分辨质谱检测28种NPS苯二氮䓬类。1913例中217例(11%)检出15种不同NPS苯二氮䓬类,男性占81%,年龄15-66岁(平均28岁);阳性率从2012年4%升至2015年19%。89%病例合并其他药物,仅15%在中毒信息中心咨询时报告使用NPS苯二氮䓬类。24例仅暴露于NPS苯二氮䓬类的患者中,中枢神经系统抑制为最突出体征,7例在ICU观察,对氟马西尼治疗有阳性反应。

要点

  • 瑞典2012-2016年1913例急诊NPS中毒中217例(11%)检出NPS苯二氮䓬类,阳性率从2012年4%升至2015年19%。
  • 检出最多的NPS苯二氮䓬类为氟溴唑仑(flubromazolam)92例,其次吡唑仑(pyrazolam)33例、氟溴西泮(flubromazepam)33例、甲氯硝西泮(meclonazepam)26例。
  • 89%病例合并其他药物,仅15%在中毒信息中心咨询时报告使用NPS苯二氮䓬类,易漏诊。
  • 24例仅暴露于NPS苯二氮䓬类的患者中,中枢神经系统抑制为最突出体征,7例在ICU观察,对氟马西尼治疗有阳性反应。

适用人群与场景

  • 2012-2016年瑞典全国医院急诊收治的连续患者,有承认或疑似摄入NPS并接受急诊治疗。
  • 经分析确认涉及NPS苯二氮䓬类的217例中毒患者,男性占81%,年龄15-66岁(平均28岁)。

研究设计与关键结果

  • 研究类型为STRIDA项目连续病例系列;1913例中217例(11%)经尿液免疫分析和液相色谱-高分辨质谱检出15种不同NPS苯二氮䓬类。
  • NPS苯二氮䓬类阳性率从2012年4%升至2015年19%。
  • 检出例数:氟溴唑仑92例、吡唑仑33例、氟溴西泮33例、甲氯硝西泮26例、乙噻唑仑20例、氯硝唑仑16例、3-羟基苯那西泮8例、尼氟西泮5例、甲噻唑仑4例、地西泮类4例、艾司唑仑2例,溴西泮、去氯乙噻唑仑、凯他唑仑、苯那西泮各1例。
  • 89%病例合并其他药物;仅15%在中毒信息中心咨询时报告使用NPS苯二氮䓬类。
  • 24例仅暴露于NPS苯二氮䓬类的患者中,中枢神经系统抑制为最突出临床体征,7例在ICU观察,对氟马西尼治疗有阳性反应。

证据类型、等级与局限

  • 证据类型:连续病例系列(STRIDA项目)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 急诊遇到疑似NPS中毒患者时应考虑NPS苯二氮䓬类可能,因89%合并其他药物且仅15%在中毒信息中心咨询时报告使用,临床识别困难。
  • 仅暴露于NPS苯二氮䓬类的患者可表现为中枢神经系统抑制,部分需ICU监护;原文报告7例在ICU观察且对氟马西尼治疗有阳性反应。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

CONTEXT: In recent years, many unclassified benzodiazepines (BZD) have appeared through online sale as new psychoactive substances (NPS). This study describes bioanalytical and clinical data related to intoxications involving NPS BZD ("designer BZD") in the Swedish STRIDA project.

STUDY DESIGN: Case series of consecutive patients with admitted or suspected intake of NPS presenting to hospitals all over Sweden for emergency treatment in 2012-2016.

PATIENTS AND METHOD: Urine samples collected in the STRIDA project were analyzed for 28 NPS BZD, using immunoassay and liquid chromatography-high-resolution mass spectrometry . Data of patient's age, gender, reported substance exposure, clinical signs, and treatment were obtained from medical and Poisons Information Center (PIC) records.

RESULTS: A total of fifteen different NPS BZD were analytically confirmed in 217 of 1913 (11%) cases involving patients (81% men) aged 15-66 (mean 28) years. The frequency of positive samples increased from 4% in 2012 to 19% in 2015. Etizolam (20 cases) was the first detected NPS BZD (January 2012), and it was followed by metizolam (four cases), estazolam (two), pyrazolam (33), flubromazepam (33), nifoxipam (five), diclazepam (four), meclonazepam (26), bromazepam (one), flubromazolam (92), deschloroetizolam (one), clonazolam (16), 3-hydroxyphenazepam (eight), ketazolam (one), and phenazepam (one). Most cases (89%) also involved other drugs. Use of NPS BZD was rarely (15%) reported during PIC consultation. In 24 patients exposed only to NPS BZD, CNS depression was the most prominent clinical sign, seven were observed in the intensive care unit, and they responded positively to flumazenil treatment.

CONCLUSIONS: An increasing use of NPS BZD in Sweden was detected in acute intoxication cases, sometimes leading to intensive care monitoring and support needs.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Bäckberg M, Pettersson Bergstrand M, Beck O, et al. Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project. Clin Toxicol (Phila). 2018. PMID: 30348014. doi:10.1080/15563650.2018.1506130

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。